- Home
- ALEC vs NMT Comparison
ALEC vs NMT Comparison
Compare ALEC & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- NMT
- Stock Information
- Founded
- ALEC 2013
- NMT 1993
- Country
- ALEC United States
- NMT United States
- Employees
- ALEC N/A
- NMT N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- NMT Finance/Investors Services
- Sector
- ALEC Health Care
- NMT Finance
- Exchange
- ALEC Nasdaq
- NMT Nasdaq
- Market Cap
- ALEC 124.0M
- NMT 108.0M
- IPO Year
- ALEC 2019
- NMT N/A
- Fundamental
- Price
- ALEC $3.20
- NMT $11.57
- Analyst Decision
- ALEC Buy
- NMT
- Analyst Count
- ALEC 7
- NMT 0
- Target Price
- ALEC $4.50
- NMT N/A
- AVG Volume (30 Days)
- ALEC 1.3M
- NMT 19.1K
- Earning Date
- ALEC 11-05-2025
- NMT 01-01-0001
- Dividend Yield
- ALEC N/A
- NMT 3.21%
- EPS Growth
- ALEC N/A
- NMT N/A
- EPS
- ALEC N/A
- NMT N/A
- Revenue
- ALEC $81,130,000.00
- NMT N/A
- Revenue This Year
- ALEC N/A
- NMT N/A
- Revenue Next Year
- ALEC $290.50
- NMT N/A
- P/E Ratio
- ALEC N/A
- NMT N/A
- Revenue Growth
- ALEC 46.77
- NMT N/A
- 52 Week Low
- ALEC $0.87
- NMT $9.05
- 52 Week High
- ALEC $6.14
- NMT $10.93
- Technical
- Relative Strength Index (RSI)
- ALEC 57.52
- NMT 52.38
- Support Level
- ALEC $3.04
- NMT $11.51
- Resistance Level
- ALEC $3.33
- NMT $11.67
- Average True Range (ATR)
- ALEC 0.20
- NMT 0.11
- MACD
- ALEC -0.03
- NMT -0.01
- Stochastic Oscillator
- ALEC 63.00
- NMT 28.88
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.